A detailed history of Ignite Planners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ignite Planners, LLC holds 4,241 shares of ABBV stock, worth $759,987. This represents 0.2% of its overall portfolio holdings.

Number of Shares
4,241
Previous 4,247 0.14%
Holding current value
$759,987
Previous $728,000 14.97%
% of portfolio
0.2%
Previous 0.19%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$163.84 - $199.33 $983 - $1,195
-6 Reduced 0.14%
4,241 $837,000
Q2 2024

Jul 12, 2024

BUY
$154.79 - $180.76 $11,918 - $13,918
77 Added 1.85%
4,247 $728,000
Q1 2024

Apr 12, 2024

SELL
$159.82 - $182.1 $159 - $182
-1 Reduced 0.02%
4,170 $759,000
Q4 2023

Jan 08, 2024

SELL
$137.6 - $154.97 $124,803 - $140,557
-907 Reduced 17.86%
4,171 $646,000
Q3 2023

Oct 10, 2023

BUY
$133.59 - $154.65 $66,928 - $77,479
501 Added 10.95%
5,078 $756,000
Q2 2023

Jul 11, 2023

SELL
$132.51 - $164.9 $11,263 - $14,016
-85 Reduced 1.82%
4,577 $616,000
Q1 2023

Apr 17, 2023

BUY
$144.61 - $166.54 $27,909 - $32,142
193 Added 4.32%
4,662 $742,000
Q4 2022

Feb 02, 2023

BUY
$138.31 - $165.87 $115,073 - $138,003
832 Added 22.88%
4,469 $722,000
Q3 2022

Oct 12, 2022

BUY
$134.21 - $153.93 $17,849 - $20,472
133 Added 3.8%
3,637 $503,000
Q2 2022

Jul 15, 2022

BUY
$137.62 - $174.96 $17,064 - $21,695
124 Added 3.67%
3,504 $533,000
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $54,903 - $68,120
416 Added 14.04%
3,380 $524,000
Q4 2021

Feb 02, 2022

BUY
$107.43 - $135.93 $318,422 - $402,896
2,964 New
2,964 $404,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ignite Planners, LLC Portfolio

Follow Ignite Planners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ignite Planners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ignite Planners, LLC with notifications on news.